
Agilent Technologies: Q3 Growth, Expanding Margins, And Raised Guidance
Seeking Alpha
Published: Aug 27, 2026, 12:45 PM
Dividend Yield Theorist 10.62K Followers Follow Summary Agilent Technologies is upgraded to Buy after a strong Q3 2026, with revenue up 8% and EPS up 18% YoY. All three segments posted robust growth, notably Life Sciences and Diagnostics, which saw operating margin jump nearly 600 bps to 23.5%. Guidance for Q4 and FY26 implies continued momentum, with management projecting 6.5–7.5% revenue growth and 8.5% EPS growth for Q4. A stock trades at a 6% discount to fair value, offering an estimated 11.38% long-term return potential supported by improved margins and recurring revenue. Fanliso/iStock Editorial via Getty Images Investment Thesis Agilent Technologies ( A ) appears to be trading for a discount at this time while also offering investors a return potential a tick above 11%. The company just announced their Q3 2026 earnings with impressive results across the board, resulting This article was written by Dividend Yield Theorist 10.62K Followers Follow I have a masters degree in Analytics from Northwestern University and a bachelors degree in Accounting. I have worked in the investment arena for over 10 years starting as an analyst and working my way up to a management role. Dividend investing is a personal hobby and I look forward to sharing my thoughts with the Seeking Alpha community. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in A over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Source: Seeking Alpha
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.